Ten firms covering Xometry have produced an average recommendation of Hold, with one Sell, four Hold and five Buy ratings. The mean 12-month price objective stands around $58. Analysts at Citizens JMP and JMP Securities both raised their targets into the mid-$70 range, while Cantor Fitzgerald lifted its neutral target to $60. Wedbush and JPMorgan Chase boosted theirs to roughly $70, reflecting increased confidence in the company’s growth trajectory following recent revenue beats.

CFO James Miln sold approximately 600 shares in early November, reducing his holding by 0.42% to just over 141,000 shares. In mid-November, engineering chief Subir Dutt sold about 2,075 shares, paring his stake by 2.83% to roughly 71,300 shares. Over the past quarter, insiders have sold a combined 12,005 shares, representing 9.66% of total insider ownership—suggesting selective liquidity rather than broad-based exit.

Major funds repositioned in Xometry during Q2: Hood River Capital Management increased its stake by 29.7%, adding nearly 93,000 shares; Squarepoint Ops grew its holdings by 33.9% with an increment of 46,500 shares; meanwhile, LVW Advisors, Sheets Smith Investment Management and Zweig DiMenna Associates established new positions ranging from $347,000 to $1.6 million. Institutional ownership now exceeds 97%. In its latest quarter, Xometry delivered revenue up 27.5% year-over-year to $180.7 million, meeting consensus EPS of $0.11 but retaining a negative net margin near 10% and a debt-to-equity ratio of 1.20.